Biogen Inc (BIIB) financials · rev $9.89B
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Biogen Inc (BIIB) rev $9.89B.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $9.89B | $9.68B |
| Cost of Revenue | $2.40B | $2.31B |
| Gross Profit | $7.49B | $7.37B |
| Net Income | $1.29B | $1.63B |
| EPS (Diluted) | $8.79 | $11.18 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $29.44B | $28.05B |
| Current Assets | $8.97B | $7.46B |
| Inventory | $2.17B | $2.46B |
| PP&E | $3.06B | $3.18B |
| Total Liabilities | $11.18B | $11.33B |
| Current Liabilities | $3.35B | $5.53B |
| Short-term Debt | N/A | $1.75B |
| Long-term Debt | $6.29B | $6.30B |
| Total Debt | $6.29B† | $8.04B† |
| Shareholders' Equity | $18.26B | $16.72B |
| Retained Earnings | $20.55B | $19.26B |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $2.20B | $2.88B |
| CapEx | $153.8M | $153.7M |
| Investing Cash Flow | -$1.37B | -$799.2M |
| Financing Cash Flow | -$301.9M | -$683.5M |
| Free Cash Flow | $2.05B | $2.72B |
FAQ
What is BIIB P/E and revenue?
Biogen Inc (BIIB) rev $9.89B.
What is BIIB revenue?
Biogen Inc last cached revenue is $9.89B (FY2025).
Is BIIB profitable?
Biogen Inc last cached net income is $1.29B (FY2025).
What are BIIB total assets?
Biogen Inc last cached total assets are $29.44B (FY2025).
What is BIIB free cash flow?
Biogen Inc last cached free cash flow is $2.05B (FY2025).
Not investment advice. Cached statements, not a live tape.